By Adam Pick on March 8, 2018
Big News! Great News! Awesome News!
Yesterday, I learned that the FDA has approved the world’s smallest mechanical heart valve replacement from Abbott for pediatric patients. This valve, known as the Masters HP 15mm mechanical heart valve, will enable doctors to treat newborns and infants needing mitral valve or aortic valve replacement.
By Adam Pick on December 12, 2017
At the Heart Valve Summit, I received a great question about sternum healing, wires and infection. Joachim asked me, “Publications have revealed that 50 to 80% of sternal infections are discovered after discharge, and that cardiac patients have the highest readmission rates. Since the sternal wires are the only force holding the sternum together after surgery, why is it that external chest supports are not a standard, adjunctive, and precautionary procedure after surgery?”
To get Joachim an expert opinion, I was very fortunate to sit down with Dr. Steve Bolling, a leading cardiac surgeon from Michigan Medicine in Ann Arbor. Here are the highlights from our chat:
By Adam Pick on November 22, 2017
Given all the recent developments about “Valve-in-Valve” procedures, my inbox is swelling up with questions. For example, Connie asked me, “I had my aortic valve replaced in 2014. What are the chances of Valve-in-Valve replacement for smaller sizes such as 21mm Edwards Magna Ease pericardial valve?”
I loved Connie’s question as it raises so many critical elements of valve therapy including valve size, valve re-operations and the new transcatheter procedures that are just now receiving FDA approval. For that reason, I wanted a “Rock Star” response to help our community learn more.
By Adam Pick on July 12, 2017
There is an outright explosion of medical advances specific to heart valve devices. In this edition of “Medical Wow!”, I’d like to introduce you to Project ImaValve.
By Adam Pick on March 22, 2017
Heart valve surgery is in a renaissance. During the last 10 years, we’ve seen an emergence of new techniques, new surgical valves, new transcatheter devices and new tissue technologies. To evaluate the safety and the effectiveness of each valvular advance, clinical trials are going on — right now — all over the world. While participating in a research study is not for everyone… Many patients are seeing positive benefits for themselves and for the next generation of patients.
A great example of this is Mr. Orest Kozinczuk from Wheaton, Illinois. Orest suffered from severe mitral regurgitation. He was tired and short-of-breath. Reflecting on his quality-of-life with mitral regurgitation, Orest told me, “My life was going down the drain.” As Orest was at high-risk for a traditional open heart procedure, Orest didn’t have many options. Then, Orest heard about a feasibility study for a new transcatheter mitral valve replacement (TMVR). This is Orest’s story.
I am so happy for Orest who is such an exceptional person. It was great spending time with him — learning about his time in the Ukraine, his career as an electrical engineer, and his inventions. Interestingly, Orest reminded me A LOT of my Grandpa Zim. Many thanks to Orest for taking the time to share his story with our community!!!